NCT06469229View on ClinicalTrials.gov

Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria

Not yet recruitingOBSERVATIONAL

Enrollment

1,200

Participants

Timeline

Start Date

July 1, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2027

Conditions

HematuriaUrothelial CarcinomaBladder CancerUreter CancerRenal Pelvis Cancer

Trial Locations (1)

Unknown

Changhai Hospital, Shanghai

All Listed Sponsors

collaborator

RenJi Hospital

OTHER

collaborator

First Hospital of China Medical University

OTHER

collaborator

Tongji Hospital

OTHER

lead

Changhai Hospital

OTHER

NCT06469229 - Performance Evaluation of Urine DNA Methylation Testing for the Detection of Urothelial Carcinoma in Patients With Hematuria | Biotech Hunter | Biotech Hunter